Eleving Group S.A. (RSE:ELEVR)

Theseus Pharmaceuticals Revenue

Eleving Group had revenue of 48.20M EUR in the quarter ending March 31, 2025, with 15.31% growth. This brings the company's revenue in the last twelve months to 190.39M, up 17.36% year-over-year. In the year 2024, Eleving Group had annual revenue of 183.89M with 18.69% growth.

• Revenue (ttm): 190.39M
• Revenue Growth: +17.36%
• P/S Ratio: 0.99
• Revenue / Employee: 64.34K
• Employees: 2,793
• Market Cap: 188.60M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	183.89M	28.96M	18.69%
Dec 31, 2023	154.93M	8.21M	5.60%
Dec 31, 2022	146.72M	18.14M	14.11%
Dec 31, 2021	128.57M	67.85M	111.73%
Dec 31, 2020	60.72M	1.72M	2.92%